Pulsenmore Expands Its Fertility Platform into the UK

Pulsenmore completed registration of its Pulsenmore FC home ultrasound system with the UK's MHRA, allowing it to be marketed across the United Kingdom and Northern Ireland. The clearance follows the system's recent European registration under the MDR and represents the company's expansion from pregnancy monitoring into fertility care. Pulsenmore FC enables women undergoing IVF and fertility preservation to perform vaginal ultrasound scans at home to monitor follicular development and endometrial thickness under remote clinical guidance, reducing repeated clinic visits. It is the company's second product to reach international markets.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.